February 11, 2008 “Intelligence: Late Breaking Lab News”

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

In an attempt to stop or delay the start of the Medicare Laboratory Competitive Demonstration Project for the San Diego-Carlsbad-San Marcos SMA (statistical metropolitan area), a lawsuit has been filed in federal court by Internist Laboratory of Carlsbad, Sharp Healthcare of San Diego, and Scripps Healthcare of San Diego. Filed on January 29 in the United States District Court for the Southern District of California, the suit names Michael Leavitt, Secretary of the Department of Health and Human Services, as defendant and seeks to enjoin him from proceeding with the competitive bidding demonstration. Unless changed by the court, February 15 is the date that laboratories wanting to participate in the competitive bidding demonstration must submit their bids.

AP CONDO LAB FIRM SUES TO STOP ANTI-MARKUP RULE

An anatomic pathology condominium (pod) lab company is also suing the federal government. On January 25, UroPath, LLC and several affiliated physician groups filed a lawsuit naming Michael Leavitt, Secretary of the Department of Health and Human Services as defendant. The action was filed in the United States District Court for the District of Columbia. UroPath and its co-plaintiffs are seeking an injunction to prevent DHHS from implementing the physician antimarkup rule that affects anatomic pathology services provided in a centralized building. (See TDR, January 21, 2008.)

IN VIVO /IN VITRO INTEGRATION AT MOLECULAR SUMMIT

Integration of in vivo and in vitro testing is a hot topic in molecular imaging and molecular diagnostics. Last week, more than 200 pathologists, radiologists, and executives from biotech, pharma, and healthcare informatics firms crowded into the first annual Molecular Summit, held in Philadelphia by THE DARK REPORT. First movers and early adopters from molecular imaging and molecular diagnostics presented on the early results of their work. One important conclusion to share with clients of THE DARK REPORT is that new molecular imaging technologies are providing radiologists with new tools to better identify and characterize tumors and similar structures in the body. However, these technologies still require confirmation by in vitro testing before the information is actionable by the patients’ physicians.

Dark Daily Update

dark_daily_logoHave you caught the latest e-briefings from DARK Daily? If so, then you’d know about…

…how several vendors are offering free EMR systems to doctors. The catch is that the EMR pages contain dynamic advertising which is linked to the information currently being viewed by the physician.

You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.

Comments

Leave a Reply

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.